Published 2021 | Version v1
Publication

Treatment of Hepatocellular Carcinoma with Immune Checkpoint Inhibitors and Applicability of First-Line Atezolizumab/Bevacizumab in a Real-Life Setting

Additional details

Created:
April 14, 2023
Modified:
November 29, 2023